Avenue Therapeutics logo

Avenue Therapeutics Share Price Today

(NASDAQ: ATXI)

Avenue Therapeutics share price is $1 & ₹86.97 as on 6 Mar 2025, 2.30 'hrs' IST

$1

Market is closed - opens 8 PM, 06 Mar 2025

View live Avenue Therapeutics share price in Dollar and Rupees. Guide to invest in Avenue Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Avenue Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Avenue Therapeutics share price movements

  • Today's Low: $0.96
    Today's High: $1.00

    Day's Volatility :3.98%

  • 52 Weeks Low: $0.96
    52 Weeks High: $15.00

    52 Weeks Volatility :93.6%

Avenue Therapeutics (ATXI) Returns

PeriodAvenue Therapeutics IncIndex (Russel 2000)
3 Months
-45.05%
0.0%
6 Months
-64.29%
0.0%
1 Year
-92.01%
0.0%
3 Years
-99.88%
-11.6%

Avenue Therapeutics (ATXI) Key Statistics

in dollars & INR

Previous Close
$1.0
Open
$0.99
Today's High
$1.0
Today's Low
$0.9602
Market Capitalization
$2.1M
Today's Volume
$13.1K
52 Week High
$15.0
52 Week Low
$0.9602
Revenue TTM
$0.0
Earnings Per Share (EPS)
$24.56
PE Ratio
0.04
Profit Margin
0.0%
Quarterly Earnings Growth YOY
-0.76%
Return On Equity TTM
-535.1%

How to invest in Avenue Therapeutics Stock (ATXI) from India?

It is very easy for Indian residents to invest directly in Avenue Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Avenue Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Avenue Therapeutics or ATXI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Avenue Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Avenue Therapeutics shares which would translate to 0.870 fractional shares of Avenue Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Avenue Therapeutics, in just a few clicks!

Returns in Avenue Therapeutics (ATXI) for Indian investors in Rupees

The Avenue Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Avenue Therapeutics investment value today

Current value as on today

₹12,936

Returns

₹87,064

(-87.06%)

Returns from Avenue Therapeutics Stock

₹92,013 (-92.01%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Avenue Therapeutics (ATXI)

-62%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Avenue Therapeutics Stock from India on INDmoney has decreased by -62% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Avenue Therapeutics

  • Ikarian Capital, LLC

    6.82%

  • BOOTHBAY FUND MANAGEMENT, LLC

    2.00%

  • UBS Group AG

    0.39%

  • Tower Research Capital LLC

    0.15%

  • Wells Fargo & Co

    0.02%

Analyst Recommendation on Avenue Therapeutics

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Avenue Therapeutics(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Avenue Therapeutics Stock (ATXI)

What analysts predicted

Upside of 700.0%

Target:

$8.00

Current:

$1.00

Insights on Avenue Therapeutics Stock (Ticker Symbol: ATXI)

  • Price Movement

    In the last 7 days, ATXI stock has moved down by -20.0%
  • ATXI vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 158.5%
  • ATXI vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 151.5%

Avenue Therapeutics Technicals Summary

Sell

Neutral

Buy

Avenue Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Avenue Therapeutics (ATXI) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Avenue Therapeutics Inc logo
-26.47%
-64.29%
-92.01%
-99.88%
-99.99%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Avenue Therapeutics Inc logo
0.04
0.04
0.0
0.0
-5.35
-4.72
NA
1.63
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Avenue Therapeutics Inc logo
Buy
$2.1M
-99.99%
0.04
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Avenue Therapeutics

Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is based in Bay Harbor Islands, Florida. Avenue Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.
Organization
Avenue Therapeutics
Employees
3
CEO
Dr. Alexandra MacLean M.D.
Industry
Health Technology

Management People of Avenue Therapeutics

NameTitle
Dr. Alexandra MacLean M.D.
CEO & Director
Mr. David Jin
Interim CFO, COO & Corporate Secretary
Dr. Lindsay Allan Rosenwald
Executive Director
Dr. Scott A. Reines M.D., Ph.D.
Interim Chief Medical Officer

Important FAQs about investing in ATXI Stock from India :

What is Avenue Therapeutics share price today?

Avenue Therapeutics share price today stands at $1.00, Open: $0.99 ; Previous Close: $1.00 ; High: $1.00 ; Low: $0.96 ; 52 Week High: $15.00 ; 52 Week Low: $0.96.

The stock opens at $0.99, after a previous close of $1.00. The stock reached a daily high of $1.00 and a low of $0.96, with a 52-week high of $15.00 and a 52-week low of $0.96.

Can Indians buy Avenue Therapeutics shares?

Yes, Indians can invest in the Avenue Therapeutics (ATXI) from India.

With INDmoney, you can buy Avenue Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Avenue Therapeutics at zero transaction cost.

How can I buy Avenue Therapeutics shares from India?

It is very easy to buy Avenue Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Avenue Therapeutics (ATXI) be purchased?

Yes, you can buy fractional shares of Avenue Therapeutics with INDmoney app.

What are the documents required to start investing in Avenue Therapeutics stocks?

To start investing in Avenue Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Avenue Therapeutics Stock (ATXI)?

Today’s highest price of Avenue Therapeutics (ATXI) is $1.00.

Today’s lowest price of Avenue Therapeutics (ATXI) is $0.96.

What is today's market capitalisation of Avenue Therapeutics?

Today's market capitalisation of Avenue Therapeutics ATXI is 2.1M

What is the 52 Week High and Low Range of Avenue Therapeutics Stock (ATXI)?

  • 52 Week High

    $15.00

  • 52 Week Low

    $0.96

What are the historical returns of Avenue Therapeutics (ATXI)?

  • 1 Month Returns

    -26.47%

  • 3 Months Returns

    -64.29%

  • 1 Year Returns

    -92.01%

  • 5 Years Returns

    -99.99%

Who is the Chief Executive Officer (CEO) of Avenue Therapeutics ?

Dr. Alexandra MacLean M.D. is the current Chief Executive Officer (CEO) of Avenue Therapeutics.